RA
Royce & Associates Portfolio holdings
AUM
$9.74B
1-Year Return
15.99%
This Quarter Return
-3.03%
1 Year Return
+15.99%
3 Year Return
+81.23%
5 Year Return
+192.6%
10 Year Return
+438.14%
AUM
$8.84B
AUM Growth
-$870M
(-9%)
Cap. Flow
-$349M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
9.41%
Holding
997
New
62
Increased
315
Reduced
362
Closed
68
Top Buys
| 1 |
Carter's
CRI
|
+$18.5M |
| 2 |
Kyndryl
KD
|
+$17.6M |
| 3 |
Enovis
ENOV
|
+$16.8M |
| 4 |
Macy's
M
|
+$16.2M |
| 5 |
Sapiens International
SPNS
|
+$15.5M |
Top Sells
| 1 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$47.6M |
| 2 |
Huntsman Corp
HUN
|
+$19.3M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
+$18.5M |
| 4 |
AVLR
Avalara, Inc.
AVLR
|
+$17.4M |
| 5 |
H&R Block
HRB
|
+$17M |
Sector Composition
| 1 | Industrials | 27.09% |
| 2 | Technology | 17.74% |
| 3 | Consumer Discretionary | 13.92% |
| 4 | Financials | 13.49% |
| 5 | Materials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRAY
651
DELISTED
ViewRay, Inc.
VRAY
| $1.7M | 0.02% |
468,000
+268,000
| +134% | +$976K |
|
652
Powell Industries
POWL
$3.34B
| $1.69M | 0.02% |
80,281
| – | – |
|
653
LifeMD
LFMD
$282M
| $1.68M | 0.02% |
852,544
+260,058
| +44% | +$512K |
|
654
Royal Gold
RGLD
$12.3B
| $1.68M | 0.02% |
17,900
| – | – |
|
|
MN
655
DELISTED
MANNING & NAPIER, INC.
MN
| $1.68M | 0.02% |
136,600
| – | – |
|
656
Gilead Sciences
GILD
$143B
| $1.67M | 0.02% |
27,000
| – | – |
|
657
Mesa Air Group
MESA
$58.6M
| $1.66M | 0.02% |
1,004,727
-911,459
| -48% | -$1.5M |
|
658
CarMax
KMX
$8.88B
| $1.65M | 0.02% |
24,975
+17,075
| +216% | +$1.13M |
|
659
Liberty Latin America Class C
LILAK
$1.54B
| $1.61M | 0.02% |
261,048
-187,800
| -42% | -$1.15M |
|
660
World Kinect Corp
WKC
$1.41B
| $1.6M | 0.02% |
68,084
-39,592
| -37% | -$928K |
|
661
Deluxe
DLX
$858M
| $1.58M | 0.02% |
95,067
-537,839
| -85% | -$8.96M |
|
|
FOCS
662
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $1.58M | 0.02% |
50,000
| – | – |
|
663
MiMedx Group
MDXG
$1.02B
| $1.56M | 0.02% |
+545,000
| New | +$1.56M |
|
664
Ameresco
AMRC
$1.48B
| $1.56M | 0.02% |
23,500
-71,000
| -75% | -$4.72M |
|
665
Ezcorp Inc
EZPW
$1.02B
| $1.55M | 0.02% |
201,000
| – | – |
|
666
GXO Logistics
GXO
$5.76B
| $1.54M | 0.02% |
+44,000
| New | +$1.54M |
|
667
Landmark Bancorp
LARK
$154M
| $1.54M | 0.02% |
69,530
-8,593
| -11% | -$190K |
|
668
Supernus Pharmaceuticals
SUPN
$2.59B
| $1.51M | 0.02% |
44,735
-156
| -0.3% | -$5.28K |
|
669
Graco
GGG
$14.1B
| $1.51M | 0.02% |
25,224
| – | – |
|
|
ATIP
670
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $1.47M | 0.02% |
29,436
| – | – |
|
671
Bioceres Crop Solutions
BIOX
$124M
| $1.47M | 0.02% |
113,000
+45,000
| +66% | +$586K |
|
672
Warrior Met Coal
HCC
$3.08B
| $1.47M | 0.02% |
51,644
+20,061
| +64% | +$571K |
|
673
NETSCOUT
NTCT
$1.8B
| $1.46M | 0.02% |
46,609
+10,553
| +29% | +$331K |
|
674
Value Line
VALU
$359M
| $1.44M | 0.02% |
32,832
-15,874
| -33% | -$697K |
|
675
MaxCyte
MXCT
$151M
| $1.44M | 0.02% |
221,325
+108,325
| +96% | +$704K |
|